Lv21
130 积分 2024-07-01 加入
CD4+ T cells in cancer
22天前
已完结
TMSB10, a potential prognosis prediction biomarker, promotes the invasion and angiogenesis of gastric cancer
25天前
已完结
CD4 + T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy
25天前
已完结
GOG-3084: A phase II trial of ADP-A2M4CD8 TCR-T cell therapy, alone or in combination with nivolumab, among patients with recurrent ovarian cancers
25天前
已完结
Chemotherapy Sparks Tertiary Lymphoid Structures in Metastatic Ovarian Cancer
27天前
已完结
Enlarged tumour-draining lymph node with immune-activated profile predict favourable survival in non-metastatic colorectal cancer
28天前
已完结
Chemotherapy Sparks Tertiary Lymphoid Structures in Metastatic Ovarian Cancer
30天前
已完结
FDA Approval Summary: Durvalumab and Pembrolizumab, Immune Checkpoint inhibitors for the Treatment of Biliary Tract Cancer
1个月前
已完结
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)
2个月前
已完结
Biomarker Insights Intensify Anti-TIGIT Design Debate
2个月前
已完结
皖公网安备34019202002308
